medroxyprogesterone
- Generic Name
- medroxyprogesterone
Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
Phase 3
Completed
- Conditions
- Osteoporosis
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- Target Recruit Count
- 150
- Registration Number
- NCT00004650
Estrogen and Graft Atherosclerosis Research Trial (EAGER)
Phase 3
Completed
- Conditions
- Coronary ArteriosclerosisMyocardial IschemiaPostmenopauseHeart DiseasesCardiovascular DiseasesCoronary Disease
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
Phase 3
Completed
- Conditions
- PostmenopauseCardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial Ischemia
Postmenopausal Estrogen/Progestin Interventions (PEPI)
Phase 3
Completed
- Conditions
- Bone DiseasesThrombosisPostmenopauseCardiovascular DiseasesCoronary DiseaseDiabetes MellitusHeart DiseasesHypercholesterolemiaHypertensionMyocardial Ischemia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath